fda and glp-1 Safety Check What Changed? The FDA's Clarification

GLP-1R agonist 2 (compound 2) is an effective GLP-1R agonist that exerts its activating effect by forming hydrogen bonds with the Tyr42, Cys71, and Ser84 residues of GLP-1R

Firms, smooths, and improves skin texture with advanced peptides

Brands that advertise access to weight loss drugs will want to develop messaging for when appointments surge

Emerging applications include non-alcoholic fatty liver disease and neurodegenerative conditions

Small, easy-to-swallow capsules with no aftertastesimply take 1 anytime you want

With antiamyloid antibodies Leqembi (lecanemab) and Kisunla (donanemab) now FDAapproved for early Alzheimers, attention is turning to combination strategies that address multiple disease pathways